Research Projects
BILECANMET – Precision medicine in cholangiocarcinoma: accurate tools for early detection and identification of PRMT5 as a novel pharmacological target
Researcher | Principal Investigator
Hepatology: Metabolism, Epigenetics and Carcinogenesis Research Group
Researcher | Principal Investigator
Hepatology: Carcinogenesis and Liquid Biopsy Research Group
Research Division
Cancer Division
Research program
Solid Tumors
Research group
Hepatology: Diagnosis and Therapeutic Response
Project information
Research project entitled BILECANMET – Precision medicine in cholangiocarcinoma: accurate tools for early detection and identification of PRMT5 as a novel pharmacological target, led by CIMA at the University of Navarra.
Principal Investigators: Matías Avila and Carmen Berasain.
Partner: María Arechederra
- Reference: TRANSCAN 2022-784-024
- Start date: January 1, 2022
- End date: December 31, 2025
- Nature of project: Regional
Need more information?
If you are interested in learning more about our research, please contact us.